Pharma Journalist -

Eli Lilly and Company has received U.S. Food and Drug Administration (FDA) approval for Onswik (insulin efsitora alfa-gobe), a once-weekly basal insulin for adults with type 2 diabetes.…
Read More...

Boehringer Ingelheim and the WHO Foundation have launched a three-year collaboration to strengthen obesity care and metabolic health services in resource-limited settings. Under the…
Read More...

Enveda has raised $311 million in a Series E financing round to advance its pipeline of medicines discovered using artificial intelligence and natural biological chemistry. The…
Read More...

Boehringer Ingelheim has partnered with AWARE Germany e.V. and AWARE Trust Zimbabwe to expand rabies prevention efforts in Tsholotsho District, one of Zimbabwe’s remote rural areas.…
Read More...

Basecamp Research has raised $140 million in a Series C financing round to develop its artificial intelligence platform and advance a pipeline of AI-designed medicines toward clinical…
Read More...

Computational technologies are reshaping RNA-targeted drug discovery, enabling researchers to identify promising therapeutic targets with greater confidence and efficiency than ever…
Read More...

Novo Nordisk and UNICEF have expanded their global partnership to prevent childhood overweight and obesity, with a new four-year program expected to reach more than 80 million children.…
Read More...

Boomray Pharmaceuticals has entered into an exclusive global licensing agreement with Novartis for a preclinical radioligand therapy (RLT) asset being developed for precision oncology.…
Read More...

Made Scientific has acquired an 85,000-square-foot cell therapy manufacturing facility in East Norriton, Pennsylvania, from National Resilience as it expands its capacity to support…
Read More...

Merck’s KEYTRUDA QLEX has been approved in Japan for subcutaneous use across all indications currently approved for KEYTRUDA, giving patients another way to receive the cancer…
Read More...